G
Grifols SA D
D
GRFS
7.11000
USD
-0.39
(-5.14%)
مغلق
حجم التداول
66,409
الربح لكل سهم
1
العائد الربحي
-
P/E
27
حجم السوق
4,837,708,729
الأخبار المقالات
العنوان: Grifols SA
القطاع: Healthcare
الصناعة: Drug Manufacturers - General
As a vertically integrated plasma derivative producer, Spain-based Grifols collects plasma and then manufactures and sells plasma-derived products globally. By acquiring Talecris in 2011, Grifols dramatically expanded its plasma-derived product portfolio, and following the firm's Biotest acquisition in April 2022, the biopharma business contributed 84% of sales in 2023. Grifols also has smaller segments including diagnostics (10% of sales) and biosupplies.